Eascra Biotech, a nanomedicine startup, has been awarded a $100,000 Stage I SBIR Targeted Technologies (START) grant funded by the Commonwealth and managed by MassVentures. The funding is to support their work on JBNps (Janus Base Nanoparticles), an advanced non-lipid nanoparticle delivery platform with superior drug delivery capabilities.
Link to article: https://www.biospace.com/press-releases/eascra-biotech-awarded-100-000-massventures-start-grant